Minerva Surgical Inc. is a medical technology company specializing in the development, manufacturing, and commercialization of minimally invasive devices for women's uterine health. Its primary focus is on providing advanced solutions for the treatment of abnormal uterine bleeding (AUB), a prevalent condition that can significantly impact women's quality of life. Minerva Surgical offers a comprehensive suite of products, including endometrial ablation systems and advanced tissue removal devices, designed as alternatives to more invasive procedures like hysterectomy. These products utilize technologies such as bipolar radiofrequency energy and enable direct intrauterine visualization, supporting safer and more precise treatments in a variety of care settings, from hospitals to physician offices. By prioritizing uterus-sparing and non-hormonal interventions, Minerva Surgical aims to address the root causes of AUB while minimizing recovery time and preserving reproductive anatomy. The company's commitment to clinical excellence, innovation, and support for gynecologic practitioners positions it as a significant player in women’s health and the broader medical device sector.